← Back to the feed

Leg&airy AG

History from 18 Feb 2020

UID

CHE-463.259.014

Legal form

AG

Canton

ZH

Founded

18 Feb 2020

Amount raised

not in the SHAB

Lead investor

not in the SHAB

Record

1. SHAB published 21 Feb 2020 · legal date 18 Feb 2020

   Company formed

   Founded 18 Feb 2020

   SHAB HR01-1004835845 ↗

2. SHAB published 27 Sep 2023 · legal date 12 Sep 2023

   Converted to an AG

   GmbH → AG

   SHAB HR02-1005846625 ↗

3. SHAB published 27 Sep 2023 · legal date 12 Sep 2023

   Capital set in the conversion to an AG

   Not assessed

   Paid in cash

   Nominal capital

   20’000 → 100’000

   Shares

   — → 10’000

   New shares, % of post-step shares

   — (conversion to an AG)

   Umwandlung: Die Gesellschaft mit beschränkter Haftung hat das Stammkapital auf CHF 100'000.00 erhöht und wird gemäss Umwandlungsplan vom 12.09.2023 und Bilanz per 30.06.2023 mit Aktiven von CHF 282'427.30 und Passiven (Fremdkapital) von CHF 83'869.48 in eine Aktiengesellschaft umgewandelt. Die Gesellschafter erhalten für ihre bisherigen Stammanteile 10'000 Namenaktien zu CHF 10.00. Rechtsform neu: Aktiengesellschaft. Aktienkapital neu: CHF 100'000.00 [bisher: CHF 20'000.00]. Liberierung Aktienkapital neu: CHF 100'000.00. Aktien neu: 10'000 vinkulierte Namenaktien zu CHF 10.00. Vinkulierung neu: Die Übertragbarkeit der Namenaktien ist nach Massgabe der Statuten beschränkt.

   SHAB HR02-1005846625 ↗

4. SHAB published 27 Sep 2023 · legal date 12 Sep 2023

   Name changed

   Leg&airy GmbH → Leg&airy AG

   SHAB HR02-1005846625 ↗

5. SHAB published 27 Jun 2025 · legal date 27 May 2025

   Capital band adopted

   SHAB HR02-1006367855 ↗

6. SHAB published 4 Sep 2025 · legal date 20 Aug 2025

   Capital increase

   ●●○Likely financing

   Paid in cash and by other means

   Nominal capital

   100’000 → 108’823.60

   Shares

   1’000’000 → 1’088’236

   New shares, % of post-step shares

   8.1% (88’236 new)

   Aktienkapital neu: CHF 108'823.60 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 108'823.60 [bisher: CHF 100'000.00]. Aktien neu: 1'088'236 Namenaktien zu CHF 0.10 [bisher: 1'000'000 Namenaktien zu CHF 0.10]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbandes.

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company was founded less than six years before this capital increase.+0.5
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.72 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006424467 ↗

7. SHAB published 27 Jan 2026 · legal date 12 Jan 2026

   Capital increase

   ●●○Likely financing

   Paid in cash

   Nominal capital

   108’823.60 → 113’235.40

   Shares

   1’088’236 → 1’132’354

   New shares, % of post-step shares

   3.9% (44’118 new)

   Aktienkapital neu: CHF 113'235.40 [bisher: CHF 108'823.60]. Liberierung Aktienkapital neu: CHF 113'235.40 [bisher: CHF 108'823.60]. Aktien neu: 1'132'354 Namenaktien zu CHF 0.10 [bisher: 1'088'236 Namenaktien zu CHF 0.10]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbandes.

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company was founded less than six years before this capital increase.+0.5
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.60 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006550632 ↗

8. SHAB published 30 Jun 2026 · legal date 16 Jun 2026

   Capital increase

   ●●○Likely financing

   Paid in cash

   Nominal capital

   113’235.40 → 117’647.20

   Shares

   1’132’354 → 1’176’472

   New shares, % of post-step shares

   3.8% (44’118 new)

   Aktienkapital neu: CHF 117'647.20 [bisher: CHF 113'235.40]. Liberierung Aktienkapital neu: CHF 117'647.20 [bisher: CHF 113'235.40]. Aktien neu: 1'176'472 Namenaktien zu CHF 0.10 [bisher: 1'132'354 Namenaktien zu CHF 0.10]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbandes.

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.60 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006691913 ↗

Published by 8 Oct 2026